A collection of stock notes from around the web.
April 6, 2009
$22 Price Target on ISIS Pharmaceutical
Zacks has a
$22 price target
on ISIS pharmaceutical this morning. They call one of their products, Mipomersen, "one of the largest potential blockbuster drugs to come to market in the next few years."
Post a Comment
Post Comments (Atom)